FORM C
International Narcotics Control Board
ANNUAL STATISTICS OF PRODUCTION, MANUFACTURE,
CONSUMPTION, STOCKS AND SEIZURES OF NARCOTIC DRUGS
Single Convention on Narcotic Drugs of 1961: articles 1, 2, 13, 20 and 27
1972 Protocol amending the Single Convention on Narcotic Drugs of 1961: articles 1 and 10
Country or Territory:
Date:
Competent office:
Responsible officer’s name:
Signature:
Title or function:
Telephone number(s):
Email:
Fax number(s):
Calendar year :
Remarks
The present form should be completed as soon as possible and not later than 30 June of the year following the year to which the statistical
data relate. The form can be downloaded from the INCB website. Once completed, the form should be sent in a single copy to:
International Narcotics Control Board
Vienna International Centre
P.O. Box 500
1400 Vienna
Austria
Telephone: (+43-1) 26060-4277 Facsimile: (+43-1) 26060-5867/5868
E-mail: [email protected]
Website: http://www.incb.org/
Seventeenth edition, December 2012
Page 2 (Form C)
General
INSTRUCTIONS
1. This form is divided into four parts:
Part I: Statistical data on manufacture, consumption, utilization and stocks of narcotic drugs
Part II: Statistical data on the manufacture of narcotic drugs
Part III: Statistical data on the licit cultivation of opium poppy and the licit production of cannabis, coca leaf and opium
Part IV: Statistical data on seizures of narcotic drugs and seizures of pharmaceutical products containing narcotic
drugs
2. In order to ensure the accurate completion of this form pursuant to the provisions of article 1 of the Single Convention on
Narcotic Drugs of 1961, the following definitions should be borne in mind:
(a)
“Consumption” means the act of supplying a narcotic drug to any person or enterprise for retail distribution,
medical use or scientific research;
(b)
“Drug” means any of the substances included in Schedules I or II of the 1961 Convention, whether natural or
synthetic, and thus subject to specific control measures under the Convention;
(c)
“Manufacture” means all processes, other than production (see the definition below), by which drugs may be
obtained and includes refining as well as the transformation of drugs into other drugs;
(d)
“Preparation” means any mixture, solid or liquid, subject to international control owing to the fact that it
contains a drug under international control. Preparations listed in Schedule III of the 1961 Convention are exempted from some
control measures;
(e)
“Production” means the separation of opium, coca leaves, cannabis and cannabis resin from the plants from
which they are obtained;
(f)
“Stocks” means the amounts of drugs held in a country or territory for domestic consumption, manufacture of
other drugs or export;
(g)
“Special stocks” means the amounts of drugs held by the Government of a country or territory for special
government purposes and to meet exceptional circumstances.
3. All drugs and preparations are listed in the List of Narcotic Drugs under International Control “Yellow List”, a supplement to
the statistical forms on narcotic drugs distributed to Governments on a yearly basis. Poppy straw produced from varieties of
opium poppy rich in codeine is referred to as “poppy straw (C)”. Poppy straw produced from varieties of opium poppy rich in
morphine is referred to as “poppy straw (M)”. Poppy straw produced from varieties of opium poppy rich in thebaine is referred to
as “poppy straw (T)”. Concentrate of poppy straw containing morphine as the main alkaloid is referred t o as “concentrate of
poppy straw (M)”. Concentrate of poppy straw containing thebaine as the main alkaloid is referred to as “concentrate of poppy
straw (T)”. Concentrate of poppy straw containing oripavine as the main alkaloid is referred to as “concentra te of poppy straw
(O)”. Concentrate of poppy straw containing codeine as the main alkaloid is referred to as “concentrate of poppy straw (C)”.
4. Figures included in the present form should be expressed in terms of the pure anhydrous drug content of the r espective
quantities of the crude drug, refined drug, base, salt or preparation, other than those listed in Schedule III of the 1961
Convention, being accounted for. All figures reported through the present form should reflect the net quantity involved, th at is,
they should not include the weight of packaging or containers (such as cases, boxes, wrappers, bottles, tubes or ampoules) an d
all figures indicating weights should be entered in kilograms and grams, or in grams and milligrams, without decimal point s or
commas. Tables showing the pure drug content of bases, esters, ethers and salts are provided in the “Yellow List” (part 4,
table 1).
5. The relevant criteria and conversion factors for tinctures and extracts of opium, coca leaf and cannabis are inclu ded in the
“Yellow List” (Part 4, table 2).
6. With respect to poppy straw and concentrate of poppy straw, the gross weights of the materials and the approximate
quantities of anhydrous morphine alkaloid (AMA), anhydrous codeine alkaloid (ACA), anhydrous thebaine alkaloid (ATA) and
anhydrous oripavine alkaloid (AOA) contained in those materials are to be reported.
Part I
7. Part I is divided into two sections:
Part I.A is to be filled out by all Governments, even if no manufacture of narcotic drugs takes place in the country or territory
under their jurisdiction (in which case the first column of table 1 should be left blank; however, data on consumption and st ocks
should be furnished in detail);
Part I.B is reserved for Governments of countries or territories that utilize or keep stocks of concentrate of poppy straw.
8. Drugs listed in part I.A have been subdivided into two groups. Those substances which should be reported to the
International Narcotics Control Board in kilograms and grams are in the first group, and those substances which are to be
reported in grams and milligrams are in the second group. The substances in both groups are listed in alphabetical order.
Page 3 (Form C)
9. Parts I.A and I.B are organized in six numbered columns (column 3 is not contained in Part I.B):
Column 1 should be used to enter data on the quantities of drugs manufactured during the year in question. The data
entered in column 1 should reflect an aggregate figure of the data entered under column 4 of part II (see the instructions below);
Column 2 should be used to enter data on the consumption of the respective narcotic drug during the year in question;
Column 3 should be used to enter data on the quantities of drugs utilised for the manufacture of Schedule III preparations
only. It is, therefore, not applicable to substances not listed in Schedule III;
Column 4 should be used to enter data on stocks held as at 31 December of the year in question;
Column 5 should be used to indicate the amounts procured for and/or withdrawn from special stocks. Whether the amount
has been procured (P) or withdrawn (W) should be clearly indicated by adding the respective initial next to each figure or by
including the relevant information in the space provided for remarks on the cover page;
Column 6 should be used to enter data on losses and destructions during the process of manufacture and wholesale
distribution of narcotic drugs. Losses and destructions should include those occurring during manufacture of raw materials,
manufacture of preparations and industrial research and development. Data referring to the destruction of obsolete materials or
preparations should also be included. Comprehensive guidelines on reporting under this column can be found at the website of
the International Narcotics Control Board (www.incb.org/incb/narcotic_drugs.html).
Part II
10. Part II is reserved for Governments of countries or territories that manufacture narcotic drugs. It is organized in four
numbered columns:
Column 1 contains a list of three varieties of poppy straw and the most commonly manufactured narcotic drugs and, at the
bottom, provides space in case parties wish to add other narcotic drugs, as may be required;
Column 2 should be used to enter the quantities of substances in column 1 used for the manufacture of substances listed in
column 3, or of other drugs as may be the case;
Column 3 contains a list of the substances most often manufactured from substances listed in column 1 and provides space
in case parties wish to add other narcotic drugs they may manufacture;
Column 4 should be used to enter the quantities of substances in column 3 manufactured from substances listed in column
1, or of other drugs as may be the case.
Part III
11. Part III is divided into two sections:
Part III.A is reserved for Governments that authorize the cultivation of opium poppy. It contains two columns for the entry of
statistical data: column 1 should be used for data on the area under cultivation (in hectares), including the total area sown and
the total area actually harvested; and column 2 should be used for data on the total quantity of substances listed in the last
column to the right (opium and/or poppy straw), obtained from the total area harvested. Quantities in column 2 should all be
entered in kilograms;
Part III.B is reserved for Governments that authorize the production of cannabis and/or coca leaf. There is no treaty
requirement for States parties to furnish the Board with statistical data on areas under cannabis plant or coca bush cultivat ion.
Statistical data on the quantities of cannabis and coca leaf produced in a country or territory should all be entered in kilo grams.
Part IV
12. Part IV is divided into two sections:
Part IV.A is to be filled out by all Governments whenever narcotic drugs (excluding pharmaceutical products) have been
seized, destroyed, used for licit purposes and/or taken over by Governments for special purposes during the year in question.
Quantities pending disposal should also be indicated;
Part IV.B is to be filled out by all Governments whenever pharmaceutical products containing narcotic drugs have been
seized. The substance and the pharmaceutical form and content of active ingredient per unit should be specified. Pharmaceutical
products seized containing other narcotic drugs than the ones listed, would have to be reported as well and their narcotic drug
content specified.
Additional remark
When completing the present form, the quantities of drugs used in the manufacture of preparations included in Schedule III of the 1961
Convention should be furnished to the Board. However, the actual quantities of Schedule III preparations consumed, held in s tocks,
procured for and withdrawn from special stocks, seized or disposed of, need not be furnished to the Board and should not be added to the
quantities of drugs reported as such. If, however, parties deem it appropriate to furnish statistical data on Schedule III preparations,
this should be clearly indicated in the space provided for remarks on the cover page.
Page 4 (Form C)
PART I.A
(For all governments)
1
Quantity
manufactured
Kilograms
Narcotic drug
Grams
Alphaprodine
Anileridine
Bezitramide
Cannabis
Cannabis resin
Coca leaf
Cocaine
Codeine
Dextromoramide
Dextropropoxyphene
Difenoxin
Dihydrocodeine
Diphenoxylate
Dipipanone
Ethylmorphine
Etorphine
Heroin
Hydrocodone
Hydromorphone
Ketobemidone
Levorphanol
a
See the instructions on page 3, paragraph 9, under column 6.
2
3
4
5
6
Quantity consumed
Quantity utilised for
the manufacture of
Schedule III
preparations
Quantity held in stocks
as at
31 December
Quantity procured (P) for or
withdrawn (W) from special
stocks
Quantity lost or
destroyed a
Kilograms
Kilograms
Grams
Grams
Kilograms
Grams
Kilograms
Grams
P/W
Kilograms
Grams
PART I.A (continued)
(For all governments)
1
Quantity
manufactured
Kilograms
Narcotic drug
Grams
2
3
4
5
6
Quantity consumed
Quantity utilised for
the manufacture of
Schedule III
preparations
Quantity held in
stocks as at
31 December
Quantity procured (P) for or
withdrawn (W) from special
stocks
Quantity lost or
destroyed a
Kilograms
Grams
Kilograms
Grams
Milligrams
Grams
Kilograms
Grams
Kilograms
Grams
P/W
Kilograms
Grams
Grams
Milligrams
Grams
Milligrams
P/W
Grams
Milligrams
Methadone
Morphine
Nicomorphine
Normethadone
Opium
Oripavine
Oxycodone
Oxymorphone
Pethidine
Phenoperidine
Pholcodine
Thebacon
Thebaine
Tilidine
Trimeperidine
Grams
Alfentanil
Fentanyl
Piritramide
Remifentanil
a
See the instructions on page 3, paragraph 9, under column 6.
Page 5 (Form C)
Sufentanil
Page 6 (Form C)
PART I.B
(Only for governments of countries or territories that utilize or keep stocks of conc entrate of poppy straw)
1
Quantity
manufactured
Narcotic drug
4
5
6
Quantity consumed
Quantity held in
stocks as at
31 December
Quantity procured (P) for or
withdrawn (W) from special
stocks
Quantity lost or
destroyed a
Kilograms
Kilograms
b
b
b
b
a
2
Grams
Kilograms
Kilograms
Grams
P/W
Kilograms
Grams
Concentrate of poppy straw (M)
b
b
b
b
AMA
c
c
c
c
ACA
c
c
c
c
ATA
c
c
c
c
AOA
c
c
c
c
Concentrate of poppy straw (T)
b
b
b
b
ATA
c
c
c
c
AMA
c
c
c
c
ACA
c
c
c
c
AOA
c
c
c
c
Concentrate of poppy straw (O)
b
b
b
b
AOA
c
c
c
c
AMA
c
c
c
c
ACA
c
c
c
c
ATA
c
c
c
c
Concentrate of poppy straw (C)
b
b
b
b
ACA
c
c
c
c
AMA
c
c
c
c
AOA
c
c
c
c
ATA
c
c
c
c
See the instructions on page 3, paragraph 9, under column 6.
Quantities to be expressed in gross weight.
c Approximate quantity of the respective anhydrous alkaloid contained in concentrate of poppy straw.
b
Grams
Page 7 (Form C)
PART II.A
(Only for governments of countries or territories that utilize narcotic drugs for the manufacture of other substances )
1
2
3
Quantity used
Substance used
Kilograms
Grams
4
Quantity obtained
Substance obtained
Kilograms
Grams
Morphine
Opium
Codeine
Thebaine
Poppy straw (M)
Concentrate of poppy straw (M)
AMA
a
ACA
b
ATA
b
AOA
b
b
Morphine
Codeine
Thebaine
Oripavine
Concentrate of poppy straw (T)
Poppy straw (T)
a
ATA
b
b
AMA
b
b
ACA
b
AOAb
b
Concentrate of poppy straw (O)
AOA
a
b
b
b
AMA
b
ACAb
b
ATA
b
b
Thebaineb
Poppy straw (C)
Concentrate of poppy straw (C)
ACA
a
AMA
b
AOA
b
ATA
b
Codeine
Papaver bracteatum
Thebaine
c
Concentrate of poppy straw (M)
AMA
a
b
Morphine
ACA
b
Codeine
ATA
b
Thebaine
AOA
b
Oripavine
Concentrate of poppy straw (T)
ATA
a
b
Thebaine
AMA
b
Morphine
ACA
b
Codeine
AOA
b
Oripavine
Concentrate of poppy straw (O)
AOA
a
b
Oripavine
AMA
b
Morphine
ACA
b
Codeine
ATA
b
Thebaine
b
Page 8 (Form C)
PART II.A (continued)
(Only for governments of countries or territories that utilize narcotic drugs for the manufacture of other substances)
1
2
3
Quantity used
Substance used
Kilograms
4
Substance obtained
Grams
Concentrate of poppy straw (C)
ACA
a
AMA
b
Morphine
AOA
b
Oripavine
ATA
b
Thebaine
b
c
Kilograms
Grams
Codeine
b
Codeine
Morphine
Residual water containing alkaloids
(please specify origin)
a
Quantity obtained
Oripavine/Thebaine
Quantities to be expressed in gross weight.
Approximate quantity of the respective anhydrous alkaloid contained in concentrate of poppy straw.
In its resolution 1982/12, the Economic and Social Council appealed to Governments which had not cultivated Papaver bracteatum to consider possibilities for refraining from
embarking on the commercial cultivation of Papaver bracteatum.
PART II.B
(Only for governments of countries or territories that utilize narcotic drugs for the manufacture of other substances )
1
Substance used
Morphine
Oripavine
Thebaine
Codeine
Oxycodone
2
3
Quantity used
Kilograms
Grams
4
Substance obtained
Codeine
Ethylmorphine
Heroin
Hydromorphone
Pholcodine
Apomorphine
Nalorphine
Hydromorphone
Oxymorphone
Thebaine
Codeine
Dihydrocodeine
Hydrocodone
Oxycodone
Thebacon
Buprenorphine
Nalbuphine
Naloxone
Naltrexone
Dihydrocodeine
Hydrocodone
Oxymorphone
Naloxone
Naltrexone
Quantity obtained
Kilograms
Grams
Page 9 (Form C)
PART II.B (continued)
(Only for governments of countries or territories that utilize narcotic drugs for the manufacture of other substances)
1
2
3
Quantity used
Substance used
Kilograms
4
Quantity obtained
Substance obtained
Grams
Kilograms
Grams
Cocaine
Coca paste
Ecgonine
Cocaine
Cocaine
Dihydrocodeine
Thebaine
Methadone
Pethidine intermediate B
Pethidine intermediate C
Pethidine
Dextromoramide
Levomoramide
Coca leaf
Coca paste
Ecgonine
Hydrocodone
Methadone intermediate
Pethidine intermediate A
Pethidine intermediate B
Pethidine intermediate C
Racemoramide
PART III.A
(Only for governments that authorize cultivation of opium poppy and/or production of opium )
1
Cultivation of opium poppy
2
Area cultivated
Sown
Harvested
Hectares
1.
Quantity produced
Opium
Poppy straw a
Kilograms
For the production of opium
2 a. For the production of
poppy straw (C) for the
manufacture of narcotic drugs
2 b. For the production of
poppy straw (M) for the
manufacture of narcotic drugs
2 c. For the production of
poppy straw (T) for the
manufacture of narcotic drugs
3. For purposes other than the
production or manufacture of
narcotic drugs
a
Requested on a voluntary basis, pursuant to Economic and Soci al Council resolution 1978/12 and to General Assembly resolution 33/168.
PART III.B
(Only for governments that authorize production of cannabis and/or coca leaf )
Cannabis production
Kilograms
Coca leaf production
Kilograms
Page 10 (Form C)
PART IV
Seizures of narcotic drugs
(For all governments)
A. Seizures of narcotic drugs (excluding pharmaceutical products) a
1
2
3
4
5
Quantity used for
licit purposes b
Quantity taken
over by the
Government for
special purposes
Seized quantity
not disposed of
pending a
decision
Kilograms
Kilograms
Disposal of seized quantities
(including those seized in previous years)
Substance
Quantity
destroyed
Quantity seized
Kilograms
Grams
Kilograms
Grams
Grams
Grams
Kilograms
Grams
Cannabis
Cannabis resin
Coca leaf
Coca paste
Cocaine
Heroin
Morphine
Opium
Others (Specify any other narcotic drug, including synthetic narcotic drugs such as fentanyl analogues.)
a
b
Quantities to be expressed in gross weight.
Governments that release seized drugs for licit medical and scientific purposes should, in addition to the gross weight of th e drug released, also report its pure anhydrous drug
content in order to facilitate the monitoring by the International Narcotics Control Board of the consumption and/or utilization of those drugs. This information may be included in
the space under “Remarks” on page 1 of form C.
B. Seizures of pharmaceutical products containing narcotic drugs
1
Ampoules
Substance
Number
of units
Content
per unit
(mg)
Pharmaceutical form and content of active ingredient per unit
2
3
4
Capsules
Patches
Tablets
Number
of units
Content
per unit
(mg)
Number
of units
Content
per unit
(mg)
Number
of units
Content
per unit
(mg)
Form
5
Other forms
Number
of units
Codeine
Fentanyl
Methadone
Morphine
Oxycodone
Pethidine
Others (Specify any other pharmaceutical product containing narcotic drugs such as dihydrocodeine, dextropropoxyphene, hydrocodone, hydromorphone, trimeperidine etc.)
Content
per unit
(mg)